Related Experiment Video
Updated: Mar 28, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Coagulopathy and the prognostic potential of D-dimer in hyperlipidemia-induced acute pancreatitis
Ning Yang1, Dong-Lei Zhang, Jian-Yu Hao
1Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China. haojianyucyyy@sina.com.
Insights
Hyperlipidemia-induced acute pancreatitis (AP) shows altered coagulation. D-dimer is a sensitive marker for AP severity, particularly in hyperlipidemia patients, indicating potential thrombosis risks.
Area of Science:
- Gastroenterology
- Hematology
- Metabolic Disorders
Background:
- Coagulopathy in acute pancreatitis (AP) and its link to hyperlipidemia (HL) remain unclear.
- Understanding coagulation homeostasis in AP is crucial for disease management.
Purpose of the Study:
- To evaluate the relationship between coagulation homeostasis and AP severity.
- To compare coagulation parameters in hyperlipidemia-induced AP (HLP) versus non-hyperlipidemia-induced AP (NHLP).
Main Methods:
- 106 AP patients were stratified by severity (mild vs. moderately severe) and etiology (HLP vs. NHLP).
- Coagulation parameters (D-dimer, protein C) and lipid metabolism were assessed.
- Correlations between disease severity, D-dimer, and protein C were analyzed.
Main Results:
- Moderately severe AP patients exhibited higher D-dimer and lower protein C levels than mild AP patients.
- HLP patients had higher protein C levels than NHLP patients.
- D-dimer and protein C levels correlated significantly with AP severity, independent of etiology. D-dimer also correlated with LDL cholesterol.
Conclusions:
- Coagulation homeostasis differs between HLP and NHLP, suggesting HL contributes to thrombosis/fibrinolysis in HLP.
- D-dimer serves as a robust marker for AP disease severity, especially in hyperlipidemia patients.
Background:
Coagulopathy and its association with disease severity in hyperlipidemia (HL)- and non-hyperlipidemia (NHL)-induced acute pancreatitis (AP) are not clear. The present study was to evaluate the relationship between coagulation homeostasis and AP.
Methods:
This study included 106 AP patients admitted to our hospital between October 2011 and January 2013. Stratified by disease severity, the patients were divided into two groups: a mild AP (MAP) group (n=69); and a moderately severe AP (MSAP) group (n=37). Based on disease etiology, there were 31 HL-induced AP (HLP) cases and 75 NHL-induced AP (NHLP) cases. The HLP and NHLP groups were compared for parameters of coagulation homeostasis, lipid metabolism, and disease severity. Correlations between disease severity and levels of D-dimer and protein C were investigated, and the prognostic potential of D-dimer was evaluated.
Results:
Compared with MAP patients, MSAP patients showed higher levels of D-dimer and lower levels of protein C. HLP patients had higher protein C levels than NHLP patients. Both D-dimer and protein C levels were significantly associated with the disease severity, not the disease etiology. D-dimer levels correlated positively with low density lipoprotein cholesterol levels and performed well as a sensitive and specific predictor of disease severity in AP patients, especially in HLP patients.
Conclusions:
The coagulation homeostasis is different between HLP and NHLP patients, and HL may be a contributing factor for thrombosis and fibrinolysis in HLP. D-dimer may be a robust marker of disease severity in HLP.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:

